Professor Brendon Noble
CSO & Director of Strategy
UK Stem Cell Foundation, The Royal Institution of Great Britain
9:00 AM Opening Keynote: Manufacturing Cell and Gene Therapy Products: Looking at the Potential and the Reality
- Analyse the industry development trends of the past 6-12months; where the industry is now and what are the biggest barriers to further development?
- Discuss the importance of ‘Flexible’ and ‘Scalable’ Manufacturing processes – why do you need to worry about this now?
- Move to Market – Identify industry developments in cost efficiency of manufacturing